scholarly journals Preoperative ureteral stent insertion within 2 months from retrograde intra-renal surgery: a useful tool to prevent postoperative infection?

2021 ◽  
Vol 32 ◽  
pp. S27
Author(s):  
V. De Stefano ◽  
C. Giulioni ◽  
S. Scarcella ◽  
S. Stramucci ◽  
G. Milanese ◽  
...  
1990 ◽  
Vol 26 (5) ◽  
pp. 871
Author(s):  
Y Yoon ◽  
D W Sung ◽  
W S Choi ◽  
D H Lee ◽  
Y T Ko ◽  
...  

Author(s):  
Marc Chalhoub ◽  
Jules Kohaut ◽  
Nicolas Vinit ◽  
Nathalie Botto ◽  
Yves Aigrain ◽  
...  

2020 ◽  
Vol 39 (11) ◽  
pp. 2077-2083 ◽  
Author(s):  
Bérénice Souhail ◽  
Patrick Charlot ◽  
Gilles Deroudilhe ◽  
Yves Coblentz ◽  
Gregory Pierquet ◽  
...  

2020 ◽  
Author(s):  
Heiko Yang ◽  
Meera Chappidi ◽  
Maya Overland ◽  
Justin Ahn ◽  
David Bayne ◽  
...  

Urology ◽  
1982 ◽  
Vol 20 (6) ◽  
pp. 650-656 ◽  
Author(s):  
Morteza K. Elyaderani ◽  
Orlando F. Gabriele ◽  
Stanley J. Kandzari ◽  
John A. Belis

BMC Urology ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jian-Hui Wu ◽  
Chun-Bai Mo ◽  
Li Dong-Zhai ◽  
Fei Luo ◽  
Qing-Tong Ma ◽  
...  

Abstract Background Ureteric stricture is a common and salvaging complications after renal transplantation. Two treatment methods are usually used, retrograde ureteral stent placement and percutaneous nephrostomy. The former has a higher failure rate, the latter has a great risk. Therefore, a safe and reliable treatment is needed. Case presentation A technique of retrograde insertion of ureteral stent was established, which was applicable in three transplant recipients with post-transplant ureteral stenosis, and the data was retrospectively recorded. The patients are 2 men and 1 woman, ages 44, 27 and 32 years. These patients underwent a total of five times of retrograde insertion of ureteral stent between 2018 and 2019. None of these patients had any postoperative complication, but all patients had complete recovery from oliguric status within two weeks. Conclusions The retrograde ureteric stent insertion by percutaneous suprapubic access to the bladder (RUS-PSAB) was demonstrated feasibility and safety in a case series with short-term follow-up. However, larger prospective studies are needed.


2017 ◽  
Vol 10 (1) ◽  
pp. 28-30
Author(s):  
Santosh Shrestha ◽  
DB Adhikari ◽  
A Gurung ◽  
S Pradhan ◽  
NV Gurung ◽  
...  

Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life.Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms.Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed.Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group.Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms.Journal of Gandaki Medical CollegeVol. 10, No. 1, 2017, page: 28-30


2015 ◽  
Vol 11 (1) ◽  
pp. 879-883 ◽  
Author(s):  
JIN-YOU WANG ◽  
HAI-LIANG ZHANG ◽  
YAO ZHU ◽  
XIAO-JIAN QIN ◽  
BO DAI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document